FujiFilm Announces Collaborations on Digital Pathology and AWS Cloud at HIMSS 2025

FUJIFILM Healthcare Americas Corporation announced two new partnerships this week at the 2025 Healthcare Information and Management Systems Society (HIMSS) meeting.

FujiFilm will partner with Tiger Health Technology to optimize data lifecycle management and address key storage-related challenges in digital pathology. This technology integration will streamline the management and accessibility of digital pathology data managed through Synapse Pathology, Fujifilm’s PACS for pathology, ensuring that healthcare providers can more efficiently handle the large volumes of information involved in pathology workflows. Further bolstering Fujifilm’s Synapse Enterprise Imaging strategy and capabilities, this partnership will enable the full integration of all digital pathology content into a healthcare organization’s vendor neutral archive (VNA), addressing any potential challenges with proprietary file format integrations.

“Our partnership with Tiger Health Technology will empower our customers to manage large whole slide images in the most effective ways. This will have a significant and positive impact on the cost of digital pathology file storage without degrading or delaying the clinical utility of these images,” said Dr. Mark Lloyd, vice president, pathology, FUJIFILM Healthcare Americas Corporation. “Together, we are committed to providing rapid access to pathology information so patients can receive the most rapid and accurate diagnosis possible.”

“Digital health platforms offer promising solutions to key challenges in healthcare systems worldwide, particularly regarding costs, productivity, and accessibility,” said Nikola Apostolov, CEO of Tiger Health Technology. “We share Fujifilm’s vision, and our partnership is a natural fit. Collaboration is the key to building sustainable healthcare platforms.”

Fujifilm and Tiger Health Technology will also collaborate to develop innovative new solutions aimed at facilitating the wider adoption of digital pathology across healthcare systems. These solutions are intended to help resolve challenges related to the efficient storage and retrieval of medical data, while also improving overall data availability for more accurate, efficient, and scalable options for diagnosis and treatment planning.

FujiFilm also entered into a new strategic agreement with Amazon Web Services (AWS), an Amazon.com, Inc. company. Additionally, AWS has validated Fujifilm’s Synapse enterprise PACS, specifically, Radiology PACS, Cardiology PACS, Digital Pathology PACS and the Synapse VNA for cloud readiness, further expanding and strengthening cloud hosting capabilities for Fujifilm’s North American Synapse Enterprise Imaging customer base.

AWS cloud services allow Fujifilm to offer its customers industry leading cloud security and the ability to scale to any size Synapse organization, supporting the Synapse customer community as they look to transition from legacy data centers to public cloud infrastructure.

Through Fujifilm’s Validated Partner status and collaborative relationship with AWS, the two companies will work together to provide new and exciting cloud hosting solutions to improve data accessibility, security, AI utilization and workflows for clinical areas including radiology, cardiology and pathology.

“We are proud to have now achieved Validated status with the AWS partner program, which includes AWS validation for cloud readiness of our core Synapse Enterprise Imaging solutions that include enterprise PACS and VNA,” says Bill Lacy, senior vice president, medical informatics, FUJIFILM Healthcare Americas Corporation. “We look forward to leveraging AWS resources and expertise to maintain the highest possible cloud performance and cloud native product design and architecture considerations moving forward. This will ensure Synapse has optimal cloud performance standards for all Synapse imaging applications.”